In an interview in the magazine IM Pharmacies, the CEO of BioSim, encarna cruz, expresses its positive assessment in relation to a "fluid and productive" dialogue that the Association maintains with the health administrations, and requests that the Law of Guarantees and Rational Use incorporate the best definition of what a biosimilar medicine is, to improve its opportunities for use.